Protagonist Therapeutics Reports Granting of Inducement Awards
NEWARK, Calif., January 6, 2025 (Ecnetnews.com) - Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 2, 2025, it issued ...
NEWARK, Calif., January 6, 2025 (Ecnetnews.com) - Protagonist Therapeutics, Inc. (Nasdaq:PTGX) today reported that on January 2, 2025, it issued ...
Online, December 19, 2024 (Ecnetnews.com) - Protagonist Therapeutics, Inc. ("Protagonist" or the "Company") today announced that Dinesh V. Patel, Ph.D., ...
SEATTLE, WA, November 29, 2024 (Ecnetnews.com) - ("Aptevo" or the "Company"), today announced that it will conduct a reverse stock ...
Online, November 25, 2024 (Ecnetnews.com) - Empyrean Therapeutics, Inc., a pioneering biopharmaceutical company, today announced the successful acquisition of a ...
MIAMI, FL, September 27, 2024 (Ecnetnews.com) - Conference presentation delivers preclinical results demonstrating Ketamir-2 achieves 100% reversal of neuropathic painMIRA ...
ECNETNews.com proudly acknowledges support from UNESCO’s International Programme for the Development of Communications, bolstering our mission to deliver accurate, unbiased news and foster informed communities across the World
ECNETNews.com is a historic important News Website running now over 20 years, since 2004 serving as neutral news source.
© 2024 ECNETNEWS - International News site for open minded news ECNETNews.com.